Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Rheumatoid Arthritis (RA) is an autoimmune disease that results in a chronic inflammatory
disorder that may affect many synovial joints, and may cause serious disability. It has been
confirmed that Tripterygium wilfordii Hook F has effects of anti-inflammatory,
immunosuppressive and cartilage protection. This is a prospective randomized controlled study
to evaluated the efficacy and safety of external application with compound Tripterygium
wilfordii Hook F in treating of patients with rheumatoid arthritis (RA).
Phase:
N/A
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences